Literature DB >> 19568407

Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer.

Geetha Srikrishna1, Hudson H Freeze.   

Abstract

Inflammatory mediators play important roles in the development and progression of cancer. Cellular stress, damage, inflammation, and necrotic cell death cause release of endogenous damage-associated molecular pattern (DAMP) molecules or alarmins, which alert the host of danger by triggering immune responses and activating repair mechanisms through their interaction with pattern recognition receptors. Recent studies show that abnormal persistence of these molecules in chronic inflammation and in tumor microenvironments underlies carcinogenesis and tumor progression, indicating that DAMP molecules and their receptors could provide novel targets for therapy. This review focuses on the role of DAMP molecules high-mobility group box 1 and S100 proteins in inflammation, tumor growth, and early metastatic events.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19568407      PMCID: PMC2697348          DOI: 10.1593/neo.09284

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  231 in total

Review 1.  Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response.

Authors:  Shi Fang Yan; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  J Mol Med (Berl)       Date:  2009-02-03       Impact factor: 4.599

2.  Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo.

Authors:  Marieke A D van Zoelen; Huan Yang; Sandrine Florquin; Joost C M Meijers; Shizuo Akira; Bernd Arnold; Peter P Nawroth; Angelika Bierhaus; Kevin J Tracey; Tom van der Poll
Journal:  Shock       Date:  2009-03       Impact factor: 3.454

Review 3.  Toll-like receptors, wound healing, and carcinogenesis.

Authors:  Johannes Kluwe; Ali Mencin; Robert F Schwabe
Journal:  J Mol Med (Berl)       Date:  2008-12-17       Impact factor: 4.599

4.  S100B/RAGE-dependent activation of microglia via NF-kappaB and AP-1 Co-regulation of COX-2 expression by S100B, IL-1beta and TNF-alpha.

Authors:  Roberta Bianchi; Ileana Giambanco; Rosario Donato
Journal:  Neurobiol Aging       Date:  2008-07-02       Impact factor: 4.673

Review 5.  Binding of S100 proteins to RAGE: an update.

Authors:  Estelle Leclerc; Günter Fritz; Stefan W Vetter; Claus W Heizmann
Journal:  Biochim Biophys Acta       Date:  2008-12-11

6.  RAGE expression in rhabdomyosarcoma cells results in myogenic differentiation and reduced proliferation, migration, invasiveness, and tumor growth.

Authors:  Francesca Riuzzi; Guglielmo Sorci; Rosario Donato
Journal:  Am J Pathol       Date:  2007-07-19       Impact factor: 4.307

Review 7.  S100B's double life: intracellular regulator and extracellular signal.

Authors:  Rosario Donato; Guglielmo Sorci; Francesca Riuzzi; Cataldo Arcuri; Roberta Bianchi; Flora Brozzi; Claudia Tubaro; Ileana Giambanco
Journal:  Biochim Biophys Acta       Date:  2008-12-07

8.  Expression of receptor for advanced glycation end products (RAGE) is related to prognosis in patients with esophageal squamous cell carcinoma.

Authors:  Taro Tateno; Shinichi Ueno; Kiyokazu Hiwatashi; Masataka Matsumoto; Hiroshi Okumura; Tetsuro Setoyama; Yasuto Uchikado; Masahiko Sakoda; Fumitake Kubo; Sumiya Ishigami; Hiroyuki Shinchi; Shoji Natsugoe
Journal:  Ann Surg Oncol       Date:  2008-11-20       Impact factor: 5.344

Review 9.  Influence of the mannose receptor in host immune responses.

Authors:  Umut Gazi; Luisa Martinez-Pomares
Journal:  Immunobiology       Date:  2009-01-21       Impact factor: 3.144

10.  A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA.

Authors:  Stanimir Ivanov; Ana-Maria Dragoi; Xin Wang; Corrado Dallacosta; Jennifer Louten; Giovanna Musco; Giovanni Sitia; George S Yap; Yinsheng Wan; Christine A Biron; Marco E Bianchi; Haichao Wang; Wen-Ming Chu
Journal:  Blood       Date:  2007-06-04       Impact factor: 22.113

View more
  121 in total

1.  The interconnectedness of cancer cell signaling.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2011-12       Impact factor: 5.715

2.  Uric acid as a novel biomarker for bone-marrow function and incipient hematopoietic reconstitution after aplasia in patients with hematologic malignancies.

Authors:  Sebastian P Haen; Vicky Eyb; Nora Mirza; Aline Naumann; Andreas Peter; Markus W Löffler; Christoph Faul; Wichard Vogel; Wolfgang A Bethge; Hans-Georg Rammensee; Lothar Kanz; Martin Heni
Journal:  J Cancer Res Clin Oncol       Date:  2017-02-16       Impact factor: 4.553

Review 3.  Host-Microbiome Cross-talk in Oral Mucositis.

Authors:  R M Vasconcelos; N Sanfilippo; B J Paster; A R Kerr; Y Li; L Ramalho; E L Queiroz; B Smith; S T Sonis; P M Corby
Journal:  J Dent Res       Date:  2016-04-06       Impact factor: 6.116

4.  S100A8/A9 activate key genes and pathways in colon tumor progression.

Authors:  Mie Ichikawa; Roy Williams; Ling Wang; Thomas Vogl; Geetha Srikrishna
Journal:  Mol Cancer Res       Date:  2011-01-12       Impact factor: 5.852

Review 5.  Programmed Cell Death and Inflammation: Winter Is Coming.

Authors:  Joseph P Kolb; Thomas H Oguin; Andrew Oberst; Jennifer Martinez
Journal:  Trends Immunol       Date:  2017-07-19       Impact factor: 16.687

Review 6.  Recent advancement in understanding colitis-associated tumorigenesis.

Authors:  Daren Low; Mari Mino-Kenudson; Emiko Mizoguchi
Journal:  Inflamm Bowel Dis       Date:  2014-11       Impact factor: 5.325

Review 7.  Ischaemia-reperfusion injury in liver transplantation--from bench to bedside.

Authors:  Yuan Zhai; Henrik Petrowsky; Johnny C Hong; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-12-11       Impact factor: 46.802

8.  The War on Cancer rages on.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

Review 9.  Cellular senescence and the senescent secretory phenotype: therapeutic opportunities.

Authors:  Tamara Tchkonia; Yi Zhu; Jan van Deursen; Judith Campisi; James L Kirkland
Journal:  J Clin Invest       Date:  2013-03-01       Impact factor: 14.808

10.  Novel interaction between proliferating cell nuclear antigen and HLA I on the surface of tumor cells inhibits NK cell function through NKp44.

Authors:  Nathan C Horton; Stephen O Mathew; Porunelloor A Mathew
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.